Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

Lannett compiling evidence to block FDA efforts to pull generic Concerta ANDA

24-Oct-2016 - Lannett is confident it can prove the extended release tech in its Concerta generic is equivalent to the original after the US FDA said it will seek withdrawal of firms ANDA.

Kempharm opts for Acura's anti-abuse tech in $3.5m deal

20-Oct-2016 - Acura Pharmaceuticals has licensed rights to use it anti-abuse technology to develop drug formulations to prodrug firm Kempharm.

Roller compactor bolsters Juniper's granulation capabilities

17-Oct-2016 - CDMO Juniper Pharma Services has added a small-scale roller compactor as the latest investment in its enabling technology offerings.

Patheon Q4 likely to suffer from hurricane-related plant closures

17-Oct-2016 - Two manufacturing facilities were closed after being hit by Hurricane Matthew earlier this month, according to a Patheon SEC filing.

Pfizer on CMOs: $180bn is at stake so being first-to-market is critical

13-Oct-2016 - With the top 500 molecules in development having a commercial potential of $180bn by 2022, being first-to-market is critical says Pfizer.

Dispatches from CPhI Worldwide 2016

Capsugel: enteric polymer comprising tech can speed-up drug development

04-Oct-2016 - Capsugel’s Vcaps Enteric offering can speed up development of delayed release drugs by removing the need for an additional enteric film coat, the firm says.

Barcelona welcomes API manufacturers and pharma firms

03-Oct-2016 - is in Barcelona to hear about market and regulatory developments in the API and CMO sectors. Check back for updates.

US FDA warns against $30 DIY alternative to Mylan's EpiPen

22-Sep-2016 - The US FDA has warned people not to use a $30 DIY epinephrine delivery device developed after Mylan increased the price of the Epipen.

Colorcon and Dow extend controlled release alliance

22-Sep-2016 - Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.

Sarepta looks to scale up production on back of its DMD drug success

20-Sep-2016 - Sarepta Therapeutics says it is considering selling its FDA priority review voucher to support manufacturing scale-up for Exondys 51, its approved Duchenne Muscular Dystrophy drug.

Shire ends pacritinib development deal with CTI post Baxalta merger

20-Sep-2016 - Shire has abandoned its partnership on CTI BioPharma’s oral kinase inhibitor pacritinib seven months after deaths in a Phase III trial halted its clinical development.

Court rules in favour of Zydus' copy of Shire's controlled-release UC drug

19-Sep-2016 - Shire says it will appeal a decision invalidating a patent surrounding the controlled-release composition of its ulcerative colitis drug Lialda (mesalazine).

Catalent to plug bioavailability tech gap with Pharmatek Laboratories buy

13-Sep-2016 - Catalent has announced its intention to buy Pharmatek Laboratories to boost its drug bioavailability offering.

LI-COR expansion offers early-phase cGMP services

12-Sep-2016 - LI-COR Biosciences has expanded its production facility to offer contract manufacturing for early-phase cGMP materials.

Spain's Idifarma bolstered by investment from API maker Suanfarma

12-Sep-2016 - Spanish API maker Suanfarma has acquired a stake in contract manufacturer and spray-drying specialist Idifarma, boosting its international presence.

Bioavailability boost: Capsugel to up micronization offering at US site

07-Sep-2016 - Capsugel plans to up micronisation capacity at Quakertown, Pennsylvania facility to provide API processing services for clinical candidates and commercial drugs.

Flexible molecules could be better drugs - for some targets

31-Aug-2016 - For drug molecules, having a flexible rather than a rigid structure can sometimes make you a better medicine, say scientists in California.

Mylan price hikes: Congress calls on FDA for generic EpiPen submission info

30-Aug-2016 - Congress has asked the US FDA for information on EpiPen generic submissions and processes in light of a series of price hikes by drugmaker Mylan.

News in brief

Agilent helps launch carbohydrate analysis lab

29-Aug-2016 - The University of Adelaide and Agilent Technologies Australia Pty have partnered on the analysis of complex carbohydrates (‘glycans’).

Hikma continues beefing up US and European manufacturing capabilities

29-Aug-2016 - Hikma invested over $25m in its US facilities in the first half 2016, and plans to use excess capacity at a former Boehringer Ingelheim plant for contract manufacturing.

Related News

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation